[go: up one dir, main page]

HRP20181357T1 - Novi postupci pročišćavanja proteina - Google Patents

Novi postupci pročišćavanja proteina

Info

Publication number
HRP20181357T1
HRP20181357T1 HRP20181357TT HRP20181357T HRP20181357T1 HR P20181357 T1 HRP20181357 T1 HR P20181357T1 HR P20181357T T HRP20181357T T HR P20181357TT HR P20181357 T HRP20181357 T HR P20181357T HR P20181357 T1 HRP20181357 T1 HR P20181357T1
Authority
HR
Croatia
Prior art keywords
protein purification
purification methods
novel protein
novel
methods
Prior art date
Application number
HRP20181357TT
Other languages
English (en)
Inventor
Arick Brown
Junyan Ji
Jun Liu
Yuchang John Wang
Original Assignee
F. Hoffmann - La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46931857&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20181357(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by F. Hoffmann - La Roche Ag filed Critical F. Hoffmann - La Roche Ag
Publication of HRP20181357T1 publication Critical patent/HRP20181357T1/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C12N7/02Recovery or purification
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011Details
    • C12N2750/14011Parvoviridae
    • C12N2750/14311Parvovirus, e.g. minute virus of mice
    • C12N2750/14351Methods of production or purification of viral material

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Water Supply & Treatment (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HRP20181357TT 2011-03-25 2012-03-23 Novi postupci pročišćavanja proteina HRP20181357T1 (hr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161467897P 2011-03-25 2011-03-25
PCT/US2012/030265 WO2012134987A1 (en) 2011-03-25 2012-03-23 Novel protein purification methods
EP12763521.7A EP2697369B1 (en) 2011-03-25 2012-03-23 Novel protein purification methods

Publications (1)

Publication Number Publication Date
HRP20181357T1 true HRP20181357T1 (hr) 2018-10-19

Family

ID=46931857

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20181357TT HRP20181357T1 (hr) 2011-03-25 2012-03-23 Novi postupci pročišćavanja proteina

Country Status (17)

Country Link
US (1) US10906934B2 (hr)
EP (1) EP2697369B1 (hr)
KR (1) KR20140022845A (hr)
CN (1) CN103582700B (hr)
AU (1) AU2012237026A1 (hr)
BR (1) BR112013024521A2 (hr)
CA (1) CA2830640A1 (hr)
ES (1) ES2685079T3 (hr)
HR (1) HRP20181357T1 (hr)
IL (1) IL228438A0 (hr)
MX (1) MX2013010737A (hr)
PL (1) PL2697369T3 (hr)
RU (1) RU2013147609A (hr)
SG (1) SG193564A1 (hr)
SI (1) SI2697369T1 (hr)
TR (1) TR201810703T4 (hr)
WO (1) WO2012134987A1 (hr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2518289C2 (ru) 2006-09-13 2014-06-10 Эббви Инк, Способ получения антитела или его фрагмента с подпиткой (варианты)
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
CN102257006A (zh) 2008-10-20 2011-11-23 雅培制药有限公司 使用a蛋白亲和层析分离和纯化抗体
SG195577A1 (en) 2008-10-20 2013-12-30 Abbott Lab Viral inactivation during purification of antibodies
PL2697369T3 (pl) 2011-03-25 2018-12-31 F.Hoffmann-La Roche Ag Nowe sposoby oczyszczania białek
US8933009B2 (en) 2013-03-12 2015-01-13 Ecolab Usa Inc. Surfactant blends for cleaning filtration membranes
HRP20240222T1 (hr) 2013-11-15 2024-04-26 F. Hoffmann - La Roche Ag Postupci inaktivacije virusa korištenjem ekološki prihvatljivih deterdženata
JP5931303B1 (ja) * 2014-08-27 2016-06-08 合同酒精株式会社 ラクターゼ溶液及びそれを用いた乳
US11697800B2 (en) 2015-11-05 2023-07-11 Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften E.V. Method for the separation of virus compositions including depletion and purification thereof
KR102316263B1 (ko) 2017-06-12 2021-10-26 아사히 가세이 메디컬 가부시키가이샤 단백질 함유액의 여과 방법
AR112957A1 (es) 2017-09-29 2020-01-08 Ecolab Usa Inc Proceso de limpieza de membrana
MX2020004151A (es) 2017-10-30 2020-08-13 Takeda Pharmaceuticals Co Detergentes compatibles con el medio ambiente para la inactivacion de virus envueltos en lipidos.
EP3752278B1 (en) 2018-02-14 2024-11-13 Ecolab USA Inc. Methods for the reduction of biofilm and spores from membranes
EP3546475A1 (en) * 2018-03-27 2019-10-02 Sanofi Full flow-through process for purifying recombinant proteins
WO2020227144A1 (en) 2019-05-03 2020-11-12 Genentech, Inc. Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform
EP4073084A1 (en) * 2019-12-12 2022-10-19 Nutrition & Biosciences USA 1, LLC Protein bioprocess
WO2022008658A1 (en) * 2020-07-10 2022-01-13 Grifols Worldwide Operations Limited Method for obtaining a composition comprising human plasma-derived immunoglobulin m
CA3185567A1 (en) * 2020-07-15 2022-01-20 Nutrition & Biosciences Usa 1, Llc Bioprocess with reduced fouling on surfaces
KR20230098589A (ko) 2020-10-30 2023-07-04 제넨테크, 인크. 감소된 가수분해 효소 활성률을 갖는 약제학적 조성물을 수득하기 위한 정제 플랫폼
CN115779683B (zh) * 2022-12-16 2024-03-22 康日百奥生物科技(苏州)有限公司 除病毒过滤方法
TW202513576A (zh) 2023-09-08 2025-04-01 美商建南德克公司 高黏度超濾/滲濾及單程切向流過濾過程

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4618533A (en) 1984-11-30 1986-10-21 Millipore Corporation Porous membrane having hydrophilic surface and process
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5017292A (en) * 1990-05-10 1991-05-21 Millipore Corporation Membrane, process and system for isolating virus from solution
AU3178993A (en) 1991-11-25 1993-06-28 Enzon, Inc. Multivalent antigen-binding proteins
KR100378500B1 (ko) 1994-07-28 2003-05-22 밀리포어 코포레이션 복합다공성막및형성방법
US5641870A (en) 1995-04-20 1997-06-24 Genentech, Inc. Low pH hydrophobic interaction chromatography for antibody purification
US5888401A (en) 1996-09-16 1999-03-30 Union Camp Corporation Method and apparatus for reducing membrane fouling
US20070059302A1 (en) * 1997-04-07 2007-03-15 Genentech, Inc. Anti-vegf antibodies
US6096872A (en) 1997-10-14 2000-08-01 Ortho Diagnostic Systems, Inc. Viral clearance process
WO2002013859A1 (fr) * 2000-08-10 2002-02-21 Chugai Seiyaku Kabushiki Kaisha Methode permettant d'inhiber la coagulation ou la turbidite d'une solution contenant des anticorps
ATE556591T1 (de) 2001-11-08 2012-05-15 Abbott Biotherapeutics Corp Stabile pharmazeutische flüssigformulierung von igg-antikörpern
AU2003212912A1 (en) 2002-02-04 2003-09-02 Millipore Corporation Process for removing protein aggregates and virus from a protein solution
DK3483183T3 (da) 2002-03-01 2021-06-21 Immunomedics Inc Immunokonjugat omfattende humaniserede rs7-antistoffer
DK1534404T3 (da) * 2002-06-14 2007-05-07 Centocor Inc Anvendelse af en klatratmodifikator til at fremme passagen af proteiner under nanofiltrering
CN1671741A (zh) * 2002-06-21 2005-09-21 拜奥根Idec公司 浓缩抗体的缓冲剂制剂及其使用方法
EP1585964A4 (en) 2002-08-28 2008-07-16 Introgen Therapeutics Inc CHROMATOGRAPHIC METHODS FOR PURIFYING ADENOVIRUSES
BRPI0416950B8 (pt) 2003-12-01 2021-05-25 Novo Nordisk Healthcare Ag métodos para remover vírus de uma composição do fator vii líquida, para inativar vírus em uma composição do fator vii líquida, e para eliminar em alto nível a presença de vírus ativos em uma composição do fator vii líquida.
AU2005229674B2 (en) 2004-11-18 2010-11-04 Kedrion Melville Inc. Low concentration solvent/detergent process of immuneglobulin with pre-treatment
GT200600031A (es) 2005-01-28 2006-08-29 Formulacion anticuerpo anti a beta
EP1869171B2 (en) 2005-04-11 2015-10-14 Crucell Holland B.V. Virus purification using ultrafiltration
EP1886976A1 (en) 2006-08-09 2008-02-13 Thermphos Trading GmbH Method of scale inhibition
US8741600B2 (en) 2007-06-19 2014-06-03 Asahi Kasei Kabushiki Kaisha Method for separation of immunoglobulin monomers
EP2412817B2 (en) * 2009-03-27 2019-06-05 Asahi Kasei Medical Co., Ltd. Method for removing viruses in high-concentration monoclonal antibody solution
AU2010292897B2 (en) 2009-08-06 2016-01-07 Genentech, Inc. Method to improve virus removal in protein purification
PL2697369T3 (pl) 2011-03-25 2018-12-31 F.Hoffmann-La Roche Ag Nowe sposoby oczyszczania białek

Also Published As

Publication number Publication date
CA2830640A1 (en) 2012-10-04
EP2697369A1 (en) 2014-02-19
US20140309403A1 (en) 2014-10-16
TR201810703T4 (tr) 2018-08-27
RU2013147609A (ru) 2015-04-27
WO2012134987A1 (en) 2012-10-04
US10906934B2 (en) 2021-02-02
IL228438A0 (en) 2013-12-31
KR20140022845A (ko) 2014-02-25
BR112013024521A2 (pt) 2019-09-24
SG193564A1 (en) 2013-10-30
EP2697369A4 (en) 2015-01-21
PL2697369T3 (pl) 2018-12-31
EP2697369B1 (en) 2018-06-27
SI2697369T1 (sl) 2018-10-30
AU2012237026A1 (en) 2013-10-24
CN103582700A (zh) 2014-02-12
ES2685079T3 (es) 2018-10-05
HK1194434A1 (zh) 2014-10-17
MX2013010737A (es) 2014-03-12
NZ615579A (en) 2016-09-30
CN103582700B (zh) 2016-08-17

Similar Documents

Publication Publication Date Title
IL228438A0 (en) New methods for protein purification
IL232558B (en) A method for antibody purification
PT2768857T (pt) Métodos para purificar anticorpos
SG10201802316VA (en) Protein purification
SI2598516T1 (sl) Postopek za čiščenje proteinov
GB201113811D0 (en) Protein recovery
PL2760558T3 (pl) Sposób oczyszczania
GB201100282D0 (en) Biological methods
SG10201606218WA (en) Purified Proteins
GB201410312D0 (en) Photobioreactor
EP2723759A4 (en) PURIFICATION OF CHIMERIC PROTEIN
EP2729672A4 (en) NEW CLEANING ARRANGEMENT
GB201119167D0 (en) Novel bachteriophages
IL229383A0 (en) A process for purifying protein with a low acidity level
EP2714713A4 (en) PURIFICATION OF ANTIBODIES
EP2768941A4 (en) photobioreactor
GB201105407D0 (en) Purification method
GB201101794D0 (en) Protein production
ZA201401261B (en) Purification process
GB201113544D0 (en) Purification process
GB201111192D0 (en) Purification process
HUP1100282A2 (en) Protein factor
GB201103169D0 (en) Protein expression
GB201100937D0 (en) Epitope purification methods
GB201113089D0 (en) Protein hydrolysates